Cambrian Bio will present two posters on ATX-304, a novel pan-AMPK and mitochondrial activator, at ADA 2026 Scientific Sessions.
Today, the American Diabetes Association ® (ADA) announced a strategic investment in UpDoc, an enterprise-ready clinical artificial intelligence (AI) company developing physician-grade agentic AI. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results